Comments on: Teva Settles Medicaid Pricing Lawsuits

By: Anne PME

Anne PME — Sun, 07 Feb 2010 22:38:33 +0000

Here in out state, Medicaid will only pay for certain ABCR drugs event though the different meds may be documented to be better at treating certain forms of MS. I worry that the pricing issues and strategies like rebates make it virtually impossible for physicians to treat their patients using evidence based medicine…with the medical evidence properly including and adding weight to the patients unique medical info…i.e patients medical file as reviewed when necessary by a qualified clinical peer

By: S

Sun, 07 Feb 2010 01:07:04 +0000

You can be certain that Teva’s generic side is squeaky clean. This is no doubt a Copaxone issue…and is something that about every Phrma mfgr has gone through. It all shakes down to what actually is the lowest price of the day!

By: Anne PME

Anne PME — Sat, 06 Feb 2010 21:21:29 +0000

I have not seen the suit but Ven-A-Care may have missed something…this may be a pretty good deal for Teva.

By: marcy stone

marcy stone — Sat, 06 Feb 2010 21:10:08 +0000

Then it’s a good match; Teva is no angel either.

By: Doc

Doc — Sat, 06 Feb 2010 00:53:34 +0000

Those folks at Ven-A-Care rock, they have extracted many millions from pharma cos, for shady business.